Influenza A virus, included in a genus of the Orthomyxoviridae family of viruses, causes pulmonary illness in birds and some mammals, including humans. Influenza A viruses are negativesense, single-stranded, segmented RNA viruses, and hence they easily undergo genetic reassortments causing unpredictable changes in its antigens resulting in recurrent pulmonary infections [1a,b] . Recently, a novel flu strain, influenza A/H1N1, known as "Swine flu", evolved as a result of a combination of influenza genes from human, pig, and bird flu, and spread globally in a short time [2] . As a consequence, the World Health Organization officially declared the outbreak of a flu pandemic on June 11, 2009 . However, the rapid emergence of drug-resistance mutations of the M2 protein among human influenza viruses restricted the use of M2 blockers, including amantidine and rimantidine. Thus, neuraminidase inhibitors, oseltamivir (Tamiflu  ) and zanamivir (Relenza  ), which inhibit the sialidase activity of neuraminidase and consequently block influenza virus release, are currently used to treat influenza infections [1a] . Recently, infection with the mutant strains of influenza viruses, which are resistant to neuraminidase, have also been reported [1a] . Thus, the development of novel therapeutic approaches against influenza infection is urgently required.
Reynoutria japonica Houtt. (Polygonaceae), also known as Polygonum cuspidatum or Fallopia japonica, is a large herbaceous perennial plant widespread across Asia, North America and Europe. It has been widely used to treat suppurative dermatitis, gonorrhea, favus athlete's foot, and hyperlipidemia in Chinese folk medicine. Various chemical components have been isolated from this plant, including naphthoquinones and phenolic compounds [3a,b] . However, the antiviral and anti-influenza effects of R. japonica, as well as its components, have not been reported previously. With regards to the anti-influenza constituents from R. japonica, two new and 12 known compounds were isolated. Moreover, the antiviral activity of the isolated compounds was also evaluated.
Compound 1 was obtained as a yellow amorphous powder and its molecular formula was determined to be C 28 signals, of which 15 were assigned to a flavonol aglycone, 12 to two sugar moieties, and 1 to a methoxy group. The 1 H-and 13 C-NMR data of 1 were similar to those of 4'-O-methylmyricitrin (7) [4] except for the signals due to a glucose moiety at C-3' of the flavonol aglycone. In the HMBC spectrum ( Figure 2 ), the methyl protons at δ H 3.92 correlated with the carbon C-4' (δ C 141.1), confirming the presence of a methoxy group at C-4'. Acid hydrolysis of 1 revealed D-glucose and L-rhamnose [5] . Furthermore, HMBC cross peaks from rha H-1" (δ H 5.38) to C-3 (δ C 136.3) and from glc H-1"' (δ H 5.38) to C-3' (δ C 152.4) suggested that the rhamnose and glucose moieties were at C-3 and C-3' of the flavonol aglycone, respectively. In addition, the β-orientation of glucose was confirmed based on the coupling constant J 1-2 = 7.8 Hz. Consequently, compound 1 was determined to be 4'-O-methylmyricitrin 3'-O-β-Dglucopyranoside.
Compound 11 was obtained as a white amorphous powder and its molecular formula was determined to be C 15 Table 2 ). The 1 H and 13 C NMR data of 11 were very similar to those of junipediol (11c) isolated from Juniperus formosana [6] and of (1S,2R,4R,5R,8S,9S)-4,8,11,11-tetramethyltricyclo[6.3.0.0 2,4 ]undecane-5,9-diol (11a) isolated from Euphorbia ebracteolata [7] . However, careful comparison of their NMR data indicated that 11 is an epimer of (1S,2R,4R,5R,8S,9S)-4,8,11,11-tetramethyltricyclo-[6.3.0.0 2,4 ] undecane-5,9-diol (11a) at C-9 [7] . Important HMBC correlations are shown in Figure 2 . The chemical shifts of C-5 (δ C 74.2) and C-12 (δ C 18.4) in 11 confirmed the R-stereochemistry at C-5 by comparison with the corresponding data of compounds with 5R-(11a) [7] [δ C values for C-5 (74.4) and C-12 (18.6)] and 5S-(11b) [8] ([δ C values for C-5 (78.0) and C-12 (12.5)] configurations. Moreover, this 5R-configuration was also supported by the chemical shifts of C-8 (δ C 50.2), C-9 (δ C 68.5), and C-10 (δ C 50.4), which differed from the corresponding data of (1S,2R,4R,5R,8S,9S)-4,8,11,11-tetramethyl-tricyclo [6.3.0.0 2,4 ]undecane-5,9-diol (11a) [δ C values for C-8 (49.1), C-9 (79.9), and C-10 (48.0)]. All these were further confirmed by NOE correlations between H-3β (δ H 0.19) and H-14 (δ H 1.08); H-3α (δ H 0.60) and H-15 (δ H 1.15) and H-5 (δ H 3.32); and between H-9 (δ H 3.92) and H-15 (δ H 1.15) ( Figure 2 ). The coupling constant between H-1 and H-2, J 1-2 = 10.8 Hz, confirmed the trans relationship between H-1 and H-2 [9] . Based on the above evidence, compound 11 was elucidated to be (1S,2R,4R,5R,8S,9R)-4,8,11,11-tetramethyltricyclo[6.3.0.0 2,4 ]undecane-5,9-diol and named reynoudiol [8] .
The known compounds were identified as quercetin 3-O-methyl ether (2) [10] , quercitrin (3) [5] , isorhamnetin 3-α-Lrhamnopyranoside (4) [11] , tamarixetin 3-α-L-rhamnopyranoside (5) [12] , myricitrin (6) [13] , 4'-O-methylmyricitrin (7) [4] , isorhamnetin 3-O-β-D-xylopyranosyl (1→2) O-β-D-glucopyranoside (8) [14] , isorhamnetin 3-O-β-D-apiofuranosyl-(1→2)-O-β-D-glucopyranoside (9) [15] , (+)-catechin (10) [16] , 7-drimene-3,11,12-triol (12) [17] , clovane-2β,9α-diol (13) [18] , and α-cadinol (14) [19] . Their structures were established based on the spectral and chemical evidence, which agreed with previous studies. We also assessed the anti-influenza activity of the compounds from R. japonica. The new compound 11 showed more effective antiinfluenza virus effects on A/PR/8/34 at the concentration of 10 µM than the positive control, oseltamivir phosphate (Figure 3 ). Since patchouli alcohol, a 11-like sesquiterpene isolated from Pogostemon cablin, has been reported to exhibit potent anti-influenza activity [20] , the antiviral activity of 11 against influenza A/PR/8/34 virus was further investigated using SRB assay in the MDCK cell line after serial dilution. Compound 11 possessed potent anti-influenza A/PR/8/34 virus activities of 90, 93, 92, 70, 13, and 3% at concentrations of 50 µM, 10 µM, 2 µM, 0.4 µM, 0.08 µM, and 0.016 µM, respectively; oseltamivir phosphate showed antiviral activity of 79, 69, 31, 4, 0.5, and 8% against influenza A/PR/8/34 virus at the same concentrations, respectively. In addition, neither 11 nor oseltamivir phosphate showed any toxic effects in MDCK cells at the concentration of 50 µM (data not shown). To confirm the effect of 11 on influenza A/PR/8/34 virus-induced CPE, we examined the morphology of MDCK cells. After 2 day infections of MDCK cells with influenza A/PR/8/34 virus, there was no difference between the non-infected cells ( Figure 5 ). In addition, the MDCK cells Overall, compound 11 had a markedly much higher (25 times) inhibitory effect against (A/PR/8/34) influenza virus when compared with oseltamivir phosphate. In conclusion, 11 showed significant inhibitory effects against influenza virus infection with an IC 50 value of 0.29 ± 0.01 µM and a CC 50 value of above 50 µM, which was more potent than that of oseltamivir phosphate with an IC 50 value of 5.85 ± 1.41 µM. Furthermore, the therapeutic index (TI) of 11 against influenza infection (171.4) was much higher than that of oseltamivir phosphate (8.6) . These results suggest that 11 might be a potential anti-influenza agent. A detailed pharmacological investigation, including animal in vivo studies, should follow to confirm this promising in vitro data.
